Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : IGT Pharma (V.IGT) Anti-Cancer Blockbuster!! -- Ignore unavailable to you. Want to Upgrade?

To: Red Hill who wrote (57)	2/10/1999 10:20:00 PM
From: Bruce Lock	Read Replies (1) \| Respond to of 86

Re: Red Hill - No Kidding... Look at IZP / Inflazyme Pharmaceuticals Ltd., 1 month ago they were trading at $0.60 today they hit a day high of $1.95 on volume of 2 million shares. They are estimating that human clinical trials for their IPL 576 (asthma) is scheduled to begin in the first half of 1999. Well... IGT Pharma have... * FDA approval for Phase 1 human clinical trial using IGT's new cancer drug ( FDA approval... Major step) * Phase I clinical trial for AVLB at the BC Cancer Agency. * Pre-clinical development of IGT-13, a new anti-cancer showing unique pre-clinical activity in the treatment of a range of cancers including multi-drug resistant cancers. * Pre-clinical development of a new class of CNS therapeutics. IMO... People will start to notice IGT Pharma.